If You Invest Just $50 per Month in the Stock Market, Here's What History Says It Could Be Worth in 20 Years

Roche's experimental eye drug shows vision improvements in trials

The S&P 500 Just Hit a Record High -- Here's How Much Higher It Can Climb, According to the Wall Street Consensus

Global equities mixed amid rising yields and oil prices

Merck's experimental eye drug meets goal in trial, but raises safety concerns